ARCHIVE

• NEW PRODUCTS
  July 18, 2005

• Otsuka: Consolidated Sales Rise 39.9% to \683,804 Mil.
  July 18, 2005

• Nippon Kayaku: Pharma Sales Fall 3.6% to \39,660 Mil.
  July 18, 2005

• Astellas Has YM155 to Treat Prostate Cancer in PII
  July 18, 2005

• R&D NEWS IN BRIEF
  July 18, 2005

• SELF-MEDICATION NEWS IN BRIEF
  July 18, 2005

• Applications for Special Regulatory Reform Zones Announced
  July 18, 2005

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  July 18, 2005

• 432 Generics Added to NHI Price List
  July 18, 2005

• JMA's Views on NHI Pricing Rule: Vice President Dr Sakurai
  July 18, 2005

• JPA's Views on NHI Pricing Rule: Vice President Urushibata
  July 18, 2005

• R&D NEWS IN BRIEF
  July 11, 2005

• Eisai to Expand Independent Marketing System in Europe
  July 11, 2005

• MEDICAL DEVICE NEWS IN BRIEF
  July 11, 2005

• Sankyo Spends Most Time on Shareholders' Meetings
  July 11, 2005

• Societies Agree to Introduce Unified Cancer Specialist Certification System
  July 11, 2005

• Mr Murakami Stresses Need for Daiichi Sankyo to Boost Share Price
  July 11, 2005

• REGULATORY NEWS IN BRIEF
  July 11, 2005

• Sankyo's Shareholders Approve Integration with Daiichi
  July 11, 2005

• NDA Review Delayed in 2004: OPIR News
  July 11, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 456
• 457
• 458
• 459
• 460
• 461
• 462
• 463
• 464
• …
• Next ›
• 最終 »